TO ASSESS ACUTE AND LATE TOXICITIES DURING  NEOADJUVANT CONCURRENT CHEMO RADIOTHERAPY IN  CARCINOMA STOMACH

Aafreen Shams, Vikram Bali Rathore, Rahul Swaroop Singh, Manjula Beck, Vivek Choudhary, Pradeep Kumar Chandrakar, Rajeev Ratan Jain, Govind Singh Gautam, Umesh Dewangan

TO ASSESS ACUTE AND LATE TOXICITIES DURING NEOADJUVANT CONCURRENT CHEMO RADIOTHERAPY IN CARCINOMA STOMACH

Authors

Aafreen Shams, Vikram Bali Rathore, Rahul Swaroop Singh, Manjula Beck, Vivek Choudhary, Pradeep Kumar Chandrakar, Rajeev Ratan Jain, Govind Singh Gautam, Umesh Dewangan

Keywords:

Acute and late toxicities, Neoadjuvant concurrent chemoradiotherapy, carcinoma stomach

Abstract

Background: The case-fatality ratio of gastric cancer is higher than for commonmalignancies like colon, breast, and prostate cancers because most patients experience vagueand nonspecific symptoms in the early stages and the classic triad of anemia, weight loss, and refusal of meat-based foods is seen only in advanced stages.

References

Lee KJ, Inoue M, Otani T, et al. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer. 2006;118:2315–21.

Olearchyk AS. Gastric carcinoma. A critical review of 243 cases. Am J Gastroenterol. 1978;70:25–45. PMid:358826

Downloads

Published

2025-09-18

How to Cite

Aafreen Shams, Vikram Bali Rathore, Rahul Swaroop Singh, Manjula Beck, Vivek Choudhary, Pradeep Kumar Chandrakar, Rajeev Ratan Jain, Govind Singh Gautam, Umesh Dewangan. (2025). TO ASSESS ACUTE AND LATE TOXICITIES DURING NEOADJUVANT CONCURRENT CHEMO RADIOTHERAPY IN CARCINOMA STOMACH . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 1972–187. Retrieved from https://ijprt.org/index.php/pub/article/view/998